Argitalpenak (10) Cristina Calviño Sampedro argitalpenak

2023

  1. Optimization of universal allogeneic CAR-T cells combining CRISPR and transposon-based technologies for treatment of acute myeloid leukemia

    Frontiers in Immunology, Vol. 14

2022

  1. CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome

    Science Advances, Vol. 8, Núm. 39

2021

  1. Distinctive cd26 expression on cd4 t-cell subsets

    Biomolecules, Vol. 11, Núm. 10

2019

  1. Design of polymeric nanocapsules to improve their lympho-targeting capacity

    Nanomedicine, Vol. 14, Núm. 23, pp. 3013-3033

  2. Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-β are targets of the autoimmune response in type 1 diabetes

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 33, Núm. 5, pp. 6390-6401

2017

  1. Apportioning Blame: Autoreactive CD4+ and CD8+ T Cells in Type 1 Diabetes

    Archivum Immunologiae et Therapiae Experimentalis, Vol. 65, Núm. 4, pp. 275-284

2015

  1. CD26 Expression on T helper populations and sCD26 serum levels in patients with rheumatoid arthritis

    PLoS ONE, Vol. 10, Núm. 7

  2. Characterization of the autoimmune response against the nerve tissue S100β in patients with type 1 diabetes

    Clinical and Experimental Immunology, Vol. 180, Núm. 2, pp. 207-217

  3. Erratum: CD26 expression on T helper populations and sCD26 serum levels in patients with rheumatoid arthritis (PLoS ONE (2015) 10:7 (e0131992) (DOI:10.1371/journal.pone.0131992))

    PLoS ONE

  4. Inmunología e inmunoterapia del cáncer colorrectal

    Abordaje multidisciplinar de cáncer colorrectal (Andavira), pp. 337-356